North America Newborn Screening Market, By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test), Product Type (Instruments, Reagents and Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays and Enzymatic Assays, Electrophoresis, DNA-Based Assays), Disease Type (Critical Congenital Heart Diseases, Newborn Hearing Loss, Sickle Cell Disease, Phenylketonuria (PKU), Cystic Fibrosis (CF), Maple Syrup Urine Disease, Others), End User (Hospital, Paediatric Clinics, Clinics), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028.
Market Analysis and Insights : North America Newborn Screening Market
North America new-born screening market is expected to witness market growth at a rate of 13.83% in the forecast period of 2021 to 2028. Data Bridge Market Research report on North America new-born screening market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the government initiatives to aware people regarding new-born screening is escalating the growth of North America new-born screening market.
Newborn screening is known to be the testing that identifies fatal and harmful disorders in new-borns which can harmfully disturb their long term health.
Major factors that are expected to boost the growth of the North America new-born screening market in the forecast period are the rise in the neonatal population base. Furthermore, the increase in the cases of congenital diseases in new-borns is further anticipated to propel the growth of the growth of the North America new-born screening market. Moreover, the suitable government programs and legislations is further estimated to cushion the growth of the North America new-born screening market. On the other hand, the rise in the expenses of automation technology and the stiff competition offered by small key players is further projected to impede the growth of the North America new born screening market in the timeline period.
In addition, the technological developments will further provide potential opportunities for the growth of the North America new-born screening market in the coming years. However, the dearth of a unified new-born screening policies and procedures around the world might further challenge the growth of the North America new-born screening market in the near future.
This North America new-born screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the North America new-born screening market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth.
North America New-born Screening Market Scope and Market Size
North America new-born screening market is segmented on the basis of test type, product type, technology, disease type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications.
- On the basis of test type, the North America new-born screening market is segmented into dried blood spot test, hearing screen test and critical congenital heart diseases (CCHD) test.
- On the basis of product type, the North America new-born screening market is segmented into instruments, reagents and assay kits.
- On the basis of technology, the North America new-born screening market is segmented into tandem mass spectrometry, hearing screen technology, pulse oximetry screening technology, immunoassays and enzymatic assays, electrophoresis, DNA-based assays.
- On the basis of disease type, the North America new-born screening market is segmented into phenylketonuria (PKU), cystic fibrosis (CF), sickle cell disease, new-born hearing loss, critical congenital heart diseases, maple syrup urine disease, others.
- On the basis of end user, the North America new-born screening market is segmented into paediatric clinics, hospital and clinics.
North America New-born Screening Market Country Level Analysis
North America new-born screening market is segmented on the basis of test type, product type, technology, disease type and end user.
The countries covered in the North America new-born screening market report are the U.S., Canada, and Mexico in North America.
United States dominates the North America new-born screening market due to the rise in the prevalence of congenital disorders and enforced testing in all 50 states. Furthermore, the growing incidence rates of disorders in new-born and the rising demand for advanced systems is further anticipated to propel the growth of the North America new-born screening market during the forecast period.
The country section of the North America new-born screening market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
North America new-born screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the North America new-born screening market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the North America new-born screening market. The data is available for the historic period 2010-2019.
Competitive Landscape and North America Newborn Screening Market Share Analysis
North America new-born screening market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the North America new-born screening market.
The major players covered in the North America new-born screening market report are PerkinElmer Inc., Natus Medical Incorporated, Trivitron Healthcare, Baebies, Inc., Bio-Rad Laboratories, Inc., Danahar, Hill-Rom Services Inc., Intelligent Hearing Systems, Interacoustics A/S, Masimo, Medtronic, Otodynamics Ltd, Vivosonic Inc., ZenTech S.A. among other. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-